Author

Elizabeth K. Vu

University of Minnesota

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 2 Assay:scRNA-seq· 1

Frequent Co-Authors

Elizabeth W. BradleyiD· 3 shared Ismael Y. KarkacheiD· 3 shared Nobuaki KikyoiD· 2 shared Nobuko Katoku-KikyoiD· 2 shared Samuel Mitchell· 2 shared Jinsha KorothiD· 1 shared Kim C. ManskyiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

Elizabeth W. BradleyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The circadian regulator PER1 inhibits osteoclastogenesis by activating inflammatory genes

Nobuko Katoku-Kikyo, Elizabeth K. Vu, Samuel Mitchell, Ismael Y. Karkache, Elizabeth W. Bradley, Nobuaki Kikyo

This study shows that PER1 inhibits osteoclastogenesis by upregulating inflammatory genes, linking circadian rhythms to bone remodeling and suggesting therapeutic targets for inflammatory bone diseases.

Journal of Bone and Mineral Research · Feb 4, 2026Peer-reviewedDevelopmental Biology

Circadian regulators PER1 and PER2 regulate osteoclastogenesis by balancing competing activities of innate immunity genes

Nobuko Katoku-Kikyo, Elizabeth K. Vu, Samuel Mitchell, Ismael Y. Karkache, Elizabeth W. Bradley, Nobuaki Kikyo

This study shows that PER1 and PER2 regulate osteoclastogenesis by balancing innate immunity gene activities, with distinct effects in single and double knockouts.

bioRxiv · Jan 11, 2026 · PreprintCell Biology

CD11B+CD36+ cells are bone anabolic macrophages that limit age-associated bone loss

Jinsha Koroth, Ismael Y. Karkache, Elizabeth K. Vu, Kim C. Mansky, Elizabeth W. Bradley

This study identifies CD11B+CD36+ macrophages as bone anabolic cells that limit age-related cortical bone loss in mice and humans.

bioRxiv · Sep 13, 2024 · PreprintCell Biology